Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Jan 2021 01:00 PM
RNS
Holding(s) in Company
20 Jan 2021 07:00 AM
RNS
Research confirms high performance of Parsortix
12 Jan 2021 07:00 AM
RNS
Change of Auditor
05 Jan 2021 07:00 AM
RNS
Issue of Equity
09 Dec 2020 07:00 AM
RNS
Parsortix can capture single cancer cell in sample
20 Nov 2020 04:18 PM
RNS
Holding(s) in Company
18 Nov 2020 04:51 PM
RNS
Holding(s) in Company
13 Nov 2020 10:46 AM
RNS
Result of General Meeting
03 Nov 2020 02:54 PM
RNS
Director/PDMR Shareholding
29 Oct 2020 07:00 AM
RNS
Interim Results
27 Oct 2020 06:28 PM
RNS
Result of Placing & Notice of General Meeting
27 Oct 2020 07:00 AM
RNS
Accelerated bookbuild to raise up to £20m
20 Oct 2020 07:00 AM
RNS
Submission accepted by FDA for substantive review
28 Sep 2020 07:00 AM
RNS
Issue of LTIP Options and Share Options
28 Sep 2020 07:00 AM
RNS
ANGLE announces completion of FDA submission
23 Sep 2020 07:00 AM
RNS
Potential treatment strategy to limit metastasis
11 Sep 2020 03:35 PM
RNS
Holding(s) in Company
11 Sep 2020 03:30 PM
RNS
Holding(s) in Company
02 Sep 2020 01:49 PM
RNS
Notification of Interim Results and Webcast
02 Sep 2020 10:00 AM
RNS
Holding(s) in Company
27 Aug 2020 03:13 PM
RNS
Result of 2020 Annual General Meeting
18 Aug 2020 09:30 AM
RNS
Holding(s) in Company
14 Aug 2020 07:00 AM
RNS
Parsortix use to assess response to immunotherapy
06 Aug 2020 12:20 PM
RNS
Holding(s) in Company
05 Aug 2020 07:00 AM
RNS
Notice of AGM and Posting of Annual Report
20 Jul 2020 07:00 AM
RNS
Study: Parsortix use in metastatic breast cancer
08 Jul 2020 05:35 PM
RNS
Holding(s) in Company
08 Jul 2020 05:30 PM
RNS
Holding(s) in Company
08 Jul 2020 05:30 PM
RNS
Holding(s) in Company
25 Jun 2020 07:00 AM
RNS
Preliminary Results
22 Jun 2020 07:00 AM
RNS
Blood donations recommenced for FDA studies
29 May 2020 07:00 AM
RNS
Notice of Results
12 May 2020 07:00 AM
RNS
CTC potential as biomarker in MET inhibitor trials
04 May 2020 07:00 AM
RNS
Leading cancer centre publishes Parsortix workflow
28 Apr 2020 07:00 AM
RNS
Business Update
17 Apr 2020 07:00 AM
RNS
Parsortix performance in head and neck cancer
31 Mar 2020 07:00 AM
RNS
COVID-19 BUSINESS IMPACT UPDATE
03 Mar 2020 07:00 AM
RNS
Assessing risk of brain metastasis in lung cancer
27 Feb 2020 07:00 AM
RNS
Parsortix outperforms other CTC systems in RCC
25 Feb 2020 07:00 AM
RNS
ANGLE announce Tri-Con presentation with BioView
17 Feb 2020 07:00 AM
RNS
Data demonstrates key advantages of Parsortix
11 Feb 2020 07:00 AM
RNS
Study demonstrates Parsortix potential in melanoma
03 Feb 2020 09:10 AM
RNS
Issue of Equity
30 Jan 2020 07:00 AM
RNS
Interim Results
30 Jan 2020 07:00 AM
RNS
Change of accounting reference date
22 Jan 2020 07:00 AM
RNS
Successful face-to-face meeting with FDA
08 Jan 2020 12:33 PM
RNS
Notice of Results
23 Dec 2019 09:55 AM
RNS
Issue of Equity
07 Nov 2019 07:00 AM
RNS
Cancer centre shows Parsortix use in melanoma
30 Oct 2019 02:44 PM
RNS
Result of AGM
UK 100

Latest directors dealings